Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

Related Articles by Review for PubMed (Select 20724523)

1.

The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 beta cells.

Garcia-Haro L, Garcia-Gimeno MA, Neumann D, Beullens M, Bollen M, Sanz P.

FASEB J. 2010 Dec;24(12):5080-91. doi: 10.1096/fj.10-166306. Epub 2010 Aug 19.

2.

Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.

Viollet B, Mounier R, Leclerc J, Yazigi A, Foretz M, Andreelli F.

Diabetes Metab. 2007 Dec;33(6):395-402. Epub 2007 Nov 7. Review.

3.

AMP-activated protein kinase in metabolic control and insulin signaling.

Towler MC, Hardie DG.

Circ Res. 2007 Feb 16;100(3):328-41. Review.

4.

Role of AMPK in pancreatic beta cell function.

Fu A, Eberhard CE, Screaton RA.

Mol Cell Endocrinol. 2013 Feb 25;366(2):127-34. doi: 10.1016/j.mce.2012.06.020. Epub 2012 Jul 3. Review.

PMID:
22766107
5.

Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models.

Viollet B, Andreelli F, Jørgensen SB, Perrin C, Flamez D, Mu J, Wojtaszewski JF, Schuit FC, Birnbaum M, Richter E, Burcelin R, Vaulont S.

Biochem Soc Trans. 2003 Feb;31(Pt 1):216-9. Review.

PMID:
12546688
6.
7.

AMPKβ subunits: more than just a scaffold in the formation of AMPK complex.

Sanz P, Rubio T, Garcia-Gimeno MA.

FEBS J. 2013 Aug;280(16):3723-33. doi: 10.1111/febs.12364. Epub 2013 Jun 24. Review.

PMID:
23721051
8.

[AMP-activated protein kinase (AMPK) as therapeutic target].

Sarnowska E, Balcerak A, Olszyna-Serementa M, Kotlarek D, Sarnowski TJ, Siedlecki JA.

Postepy Hig Med Dosw (Online). 2013 Aug 5;67:750-60. Review. Polish.

9.

Advances in the research of AMPK and its subunit genes.

Liu WY, Jiang RS.

Pak J Biol Sci. 2013 Nov 15;16(22):1459-68. Review.

PMID:
24511687
10.

Protein phosphatases in pancreatic islets.

Ortsäter H, Grankvist N, Honkanen RE, Sjöholm Å.

J Endocrinol. 2014 Jun;221(3):R121-44. doi: 10.1530/JOE-14-0002. Epub 2014 Mar 28. Review.

11.

AMPK inhibition in health and disease.

Viollet B, Horman S, Leclerc J, Lantier L, Foretz M, Billaud M, Giri S, Andreelli F.

Crit Rev Biochem Mol Biol. 2010 Aug;45(4):276-95. doi: 10.3109/10409238.2010.488215. Review.

12.

Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors.

Eto M.

J Biol Chem. 2009 Dec 18;284(51):35273-7. doi: 10.1074/jbc.R109.059972. Epub . Review.

14.

Structural basis for protein phosphatase 1 regulation and specificity.

Peti W, Nairn AC, Page R.

FEBS J. 2013 Jan;280(2):596-611. doi: 10.1111/j.1742-4658.2012.08509.x. Epub 2012 Feb 24. Review.

15.

Past strategies and future directions for identifying AMP-activated protein kinase (AMPK) modulators.

Sinnett SE, Brenman JE.

Pharmacol Ther. 2014 Jul;143(1):111-8. doi: 10.1016/j.pharmthera.2014.02.008. Epub 2014 Feb 26. Review.

16.

Protein phosphatase 1 catalytic isoforms: specificity toward interacting proteins.

Korrodi-Gregório L, Esteves SL, Fardilha M.

Transl Res. 2014 Nov;164(5):366-91. doi: 10.1016/j.trsl.2014.07.001. Epub 2014 Jul 8. Review.

PMID:
25090308
17.

Targeting the untargetable: recent advances in the selective chemical modulation of protein phosphatase-1 activity.

Chatterjee J, Köhn M.

Curr Opin Chem Biol. 2013 Jun;17(3):361-8. doi: 10.1016/j.cbpa.2013.04.008. Epub 2013 May 3. Review.

PMID:
23647984
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk